Despite complete surgical resection, a substantial proportion of patients with early-stage non-small-cell lung cancer (NSCLC) ...

Kite, the Santa Monica, California-based cell therapy subsidiary of Gilead, has entered a definitive agreement to pay $350 ...

In phase 3 APOLLO trial, ATRA-ATO combination therapy showed superior outcomes for high-risk acute promyelocytic leukemia.

Gene and Molecular Therapy Publication Trend The graph below shows the total number of publications each year in Gene and Molecular Therapy.

The National Cancer Institute-Molecular Analysis for Therapy Choice (NCI-MATCH) trial was implemented to identify actionable genetic alterations across cancer types and enroll patients accordingly ...

Data from new publication in the journal “Molecular Therapy” show OST-HER2 induces strong innate and cytotoxic immune responses beginning at the 1st dose of 3 dose regimen, that correlate with ...

Discover how CRISPR gene editing is creating personalized cancer therapies, enhancing immunotherapy, and offering new hope for hard-to-treat cancers.

4D Molecular Therapeutics has posted 60-week data on a gene therapy, providing evidence of durability in diabetic macular edema (DME) and sending its stock up more than 40% in premarket trading ...

Jason Bergsbaken, PharmD, MBA, BCOP, explains the value of pharmacist involvement in precision molecular tumor boards and end-of-life care discussions, highlighting their role in ensuring ...

Christopher Evans, PhD, of Mayo Clinic, has been developing a gene therapy for osteoarthritis, which causes joint pain in adults. In osteoarthritis patients, the cushion of cartilage at the ends of ...

Molecular Partners ( ($MLLCF) ) has released its Q2 earnings. Here is a breakdown of the information Molecular Partners presented to its ...

Learn how Nature Research Intelligence gives you complete, forward-looking and trustworthy research insights to guide your research strategy.